Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk.

Journal Article (Journal Article;Multicenter Study)

The authors previously identified plasma plasminogen activator inhibitor-1 (PAI-1) level as a quantitative lung injury biomarker in primary graft dysfunction (PGD). They hypothesized that plasma levels of PAI-1 used as a quantitative trait could facilitate discovery of genetic loci important in PGD pathogenesis. A two-stage cohort study was performed. In stage 1, they tested associations of loci with PAI-1 plasma level using linear modeling. Genotyping was performed using the Illumina CVD Bead Chip v2. Loci meeting a p < 5 × 10(-4) cutoff were carried forward and tested in stage 2 for association with PGD. Two hundred ninety-seven enrollees were evaluated in stage 1. Six loci, associated with PAI-1, were carried forward to stage 2 and evaluated in 728 patients. rs3168046 (Toll interacting protein [TOLLIP]) was significantly associated with PGD (p = 0.006). The increased risk of PGD for carrying at least one copy of this variant was 11.7% (95% confidence interval 4.9-18.5%). The false-positive rate for individuals with this genotype who did not have PGD was 6.1%. Variants in the TOLLIP gene are associated with higher circulating PAI-1 plasma levels and validate for association with clinical PGD. A protein quantitative trait analysis for PGD risk prioritizes genetic variations in TOLLIP and supports a role for Toll-like receptors in PGD pathogenesis.

Full Text

Duke Authors

Cited Authors

  • Cantu, E; Suzuki, Y; Diamond, JM; Ellis, J; Tiwari, J; Beduhn, B; Nellen, JR; Shah, R; Meyer, NJ; Lederer, DJ; Kawut, SM; Palmer, SM; Snyder, LD; Hartwig, MG; Lama, VN; Bhorade, S; Crespo, M; Demissie, E; Wille, K; Orens, J; Shah, PD; Weinacker, A; Weill, D; Wilkes, D; Roe, D; Ware, LB; Wang, F; Feng, R; Christie, JD; Lung Transplant Outcomes Group,

Published Date

  • March 2016

Published In

Volume / Issue

  • 16 / 3

Start / End Page

  • 833 - 840

PubMed ID

  • 26663441

Pubmed Central ID

  • PMC4767612

Electronic International Standard Serial Number (EISSN)

  • 1600-6143

Digital Object Identifier (DOI)

  • 10.1111/ajt.13525


  • eng

Conference Location

  • United States